USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy.
Ma T, Chen W, Zhi X, Liu H, Zhou Y, Chen BW, Hu L, Shen J, Zheng X, Zhang S, Zhang B, Li H, Liang T.
Ma T, et al. Among authors: chen bw, chen w.
Cancer Lett. 2018 Nov 1;436:129-138. doi: 10.1016/j.canlet.2018.08.010. Epub 2018 Aug 15.
Cancer Lett. 2018.
PMID: 30118840